This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Vaccinia Virus Protein OPG161 (OPG161), N-GST and C-His
Product Overview
BioVenic's Recombinant Vaccinia Virus Protein OPG161 (OPG161), N-GST and C-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 39.1 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
The Vaccinia virus protein OPG161 (A33R) is a major antigenic protein that plays a significant role in the immune response to the virus. In veterinary medicine, OPG161 is used in diagnostic tests to detect antibodies against vaccinia virus, helping to monitor the effectiveness of vaccination programs. It is also a target for vaccine development due to its ability to induce a strong immune response.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.